Capillary Technologies India Limited (CAPILLARY) surged +10% to break out above its 6-month resistance trendline, now trading at ₹546.5 on the NSE. This breakout was backed by the company’s Q1 FY2027 results, which showed a robust 43% year-on-year growth in operating revenue and a 132% surge in adjusted EBITDA. In the technology sector, particularly within software infrastructure, this move highlights Capillary’s strong performance amidst a backdrop of sector-wide consolidation.

Technical setup — trendlines & DMA

The current 6-month trendline structure shows a solid support floor at ₹466.56, which is 14.63% below today’s price, indicating a strong base. Resistance was previously at ₹511.86, which the stock has now cleared by 6.34%, signaling a potential upward momentum. The 50-DMA stands at ₹504.1, slightly below the current price, while the 200-DMA is at ₹561.1, suggesting the stock is still in a consolidating phase. In its 52-week range of ₹464.2 to ₹799.0, the stock is in the lower third, indicating there’s room for further upside if the positive momentum continues.

Fundamentals & business context

With a PE ratio of 72.2 and profit margins at 7.1%, Capillary Technologies is trading at a premium, reflecting investor optimism about its high revenue CAGR of 42.2%. However, the absence of profit CAGR raises questions about the sustainability of these high valuations. The 20.6% institutional ownership suggests that while there is some confidence from smart money, the high PE and thin margins may indicate a stretched valuation relative to current earnings. Today’s move is clearly driven by the strong Q1 results, underscoring the market’s positive reaction to the company’s financial performance.

Algorithmic scorecard

The overall algorithmic scorecard reflects a balanced view of Capillary Technologies, with a slight edge towards fundamental strength. The strongest signals come from the company’s excellent revenue CAGR of 42.2% and its very low debt levels, indicating strong growth potential and financial health. However, the weak signals are the low profit margin of 7.1% and negligible dividend yield, which pose risks in terms of profitability and income generation for investors. The stock’s bearish trend, as indicated by the 50-DMA being below the 200-DMA, and its position near the yearly lows in the 52-week range, also suggest caution in the near term.

Company outlook

Capillary Technologies’ management has outlined an optimistic outlook for the coming fiscal year. They expect EBITDA margins to remain sustainable, with a target of reaching a steady-state EBITDA margin of 25-30%. Revenues are projected to exceed INR 1,000-1,050 crores in FY27, driven by both organic growth and the SessionM acquisition. The company plans to focus on maintaining a 115% NRR on the organic business while targeting upgrades on the inorganic side to enhance margins. Additionally, an AI-led platform is in development to facilitate the upgrade of customers from acquired stacks to Capillary, aiming to accelerate margin improvements and integration efforts.

Get all details on CAPILLARY — P&L, peers, shareholding and more on TradeAlone.